Inspecs Group (LSE:SPEC) Beta: 2.0803 (As of Jun. 26, 2026)


LSE:SPEC Inspecs Group PLC LSE:SPEC
52 GF Score
Price £0.97
GF Value £0.58
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Inspecs Group Beta?

Inspecs Group LSE:SPEC 52 Beta is 2.0803 as of Jun. 26, 2026. GuruFocus rates LSE:SPEC with a GF Score™ of 52/100 and a GF Value™ of £0.58 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-26), Inspecs Group's Beta is 2.0803.


Inspecs Group  (LSE:SPEC) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Inspecs Group Beta Related Terms


Inspecs Group Beta Historical Data

* Premium members only.

The historical data trend for Inspecs Group's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inspecs Group Beta Chart

Inspecs Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 3.36 3.52 4.05

Inspecs Group Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.36 3.45 3.52 3.19 4.05

LSE:SPEC vs ISRG, BDX, MDLN: Beta Comparison

For the Medical Instruments & Supplies subindustry, Inspecs Group's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Inspecs Group Beta vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Inspecs Group's Beta distribution charts can be found below:

* The bar in red indicates where Inspecs Group's Beta falls into.


LSE:SPEC
52GF Score
Inspecs Group PLC LSE:SPEC
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Inspecs Group Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 2.0803 mean?
Inspecs Group (LSE:SPEC) has a Beta of 2.0803 as of Jun. 26, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Inspecs Group and its competitors.
Is Inspecs Group's Beta too high?
Inspecs Group's current Beta is 2.0803. Overall, Inspecs Group has a GF Score™ of 52/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Inspecs Group's Beta compare to ISRG and BDX?
Inspecs Group's Beta of 2.0803 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Medical Devices & Instruments company?
A good Beta depends on the Medical Devices & Instruments industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Inspecs Group and its competitors. Inspecs Group's current Beta is 2.0803. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inspecs Group stock overvalued right now?
Based on GuruFocus' analysis, Inspecs Group (LSE:SPEC) is currently considered Significantly Overvalued. The stock's GF Value™ is £0.58, compared to a current price of £0.97 — trading 67.2% above its estimated fair value. The current Beta is 2.0803. Inspecs Group's overall GF Score™ is 52/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Inspecs Group (LSE:SPEC), the current Beta is 2.0803 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Inspecs Group (LSE:SPEC) Overvalued in 2026?

Based on GuruFocus' analysis, Inspecs Group stock appears to be overvalued. The current stock price of £0.97 is trading 67.2% above its estimated GF Value™ of £0.58. GuruFocus considers Inspecs Group to be Significantly Overvalued.

Key valuation signals for LSE:SPEC:

  • Beta: 2.0803
  • GF Value™: £0.58 vs. price of £0.97 (67.2% above fair value)
  • GF Score™: 52/100 with 6 warning signs

No single metric tells the full story. See the LSE:SPEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Inspecs Group Business Description

Address Upper Bristol Road, 7-10 Kelso Place, Bath, Somerset, GBR, BA1 3AU
Inspecs Group PLC is a designer and manufacturer of eyewear frames and accessories. The customers of the company include optical and Non-optical retailers, distributors, and independent opticians. The company operations are spread across the United Kingdom, Europe (excluding the UK), South America, North America, Asia, Africa, and Australia. Its eyewear brands include Superdry, Titanflex, O'Neill, Brendel, Humphreys, Marc O'Polo, and among others. The reporting segments of the company are Frames and Optics product distribution which derives maximum revenue, and Manufacturing includes OEM and manufacturing distribution segment.
52GF Score

Get the complete analysis for LSE:SPEC

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£0.97
Price
£0.58
GF Value